Recognized by industry leaders for extensive coverage on African Asset Management
Adjuvant Capital leads $15m Series A round for 54gene
This product is currently unavailable.
Description
687
Adjuvant Capital, a health-focused investment firm backed by IFC and the Bill & Melinda Gates Foundation, have led a Series A round of $15m in 54gene, an African genomics research, services, and development company.
